BMS Positions Breyanzi for Another Indication as LOE Woes Mount
Adding a new indication for the CAR T cell therapy could help BMS offset the loss-of-exclusivity headwinds it faces in the coming years.
BMS Positions Breyanzi for Another Indication as LOE Woes Mount Read More »
